Pushing research forward
The future of health is in our hands.
Support IDIBELL’s research.
RESEARCH PROJECTS
140
national competitive projects granted in 2022 worth
19.293.590,15 €
23
international competitive projects granted in 2022 worth
6.168.242,51 €
Innovation
& Business development
IDIBELL facilitates and promotes the transfer of the knowledge generated by its researchers through clinical trials, patents, codevelopment agreements or the creation of spin-off companies. Since 2020, priorities included adding more value to the portfolio and designing new strategies for internationalization to become more competitive worldwide.
Innovation competitive projects
12 national projects
(worth 1,619,552.43 €)
200 new clinical trials
4 internal promoter
196 external promoter
133 active patents
belonging to 28 families
19 licences &
6 active spin-offs
TRACTIVUS
312 projects in portfolio
Including m-health & medical devices, technologies, drug discovery & personalised medicine
58 R+D contracts
43 national
15 international